"U.S. Patents Are Granted for 3 Laboratory Mice"

Important note: Information in this article was accurate in 1992. The state of the art may have changed since the publication date.

"U.S. Patents Are Granted for 3 Laboratory Mice"

Washington Post (12/30/92), P. A4

Abstract: The federal government granted three patents yesterday to strains of genetically altered mice. Researchers consider the patents critical for biotechnology. They are the first since 1988 to recognize ownership of a genetically altered animal species. The U.S. Patent and Trademark Office (PTO) notified its Official Gazette that it was issuing patents for laboratory mouse strains to Harvard University, GenPharm International of Mountain View, Calif., and Ohio University. GenPharm was granted a patent for a mouse strain that has been altered so that it naturally fails to develop a fully functional immune system. The GenPharm mouse was genetically altered by the addition of aJgene that prevents the rodent from developing fully mature lymphocytes. The new mouse will be used in the study of immune-system diseases such as AIDS, or in research on autoimmune diseases, said Jonathan MacQuitty, chief operations officer of GenPharm.

921230
AD922513

Copyright © 1992 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.

Always watch for outdated information. This article first appeared in 1992. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1992. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.